Table 6. Clinical trial efficacy data of new drug monotherapy.
Abbreviations: —, not available; ALK, anaplastic lymphoma kinase; CTCL, cutaneous T‐cell lymphoma; CR, complete remission; Cru, unconfirmed complete remission; DoR, duration of response; ORR, overall response rate; OS, overall survival; MoAb, monoclonal antibodies; NK, natural killer; PFS, progression‐free survival; PI3K, phosphoinositide‐3 kinase; PTCL, peripheral T‐cell lymphoma; Ref., reference.